AstriVax

Description: AstriVax develops a Plug & Play DNA-based vaccination platform for infectious diseases, spun off from KU Leuven in 2022.

Country: Belgium

Based in: Heverlee

Founded: 2022

Funding Stage: Pre-Seed

Tags: ['Pipeline', 'Vaccination', 'DNA-based technology']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.